跳至主要内容
临床试验/NCT01361230
NCT01361230已完成不适用

PILOT STUDY: A Randomized Controlled Trial of Intensive Care Management of Sedation Using Patient Responsiveness in Critical Care IMPROVE Critical Care Study Pilot

GE Healthcare1 个研究点 分布在 1 个国家目标入组 74 人开始时间: 2009年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
GE Healthcare
入组人数
74
试验地点
1
主要终点
Proportion of time spent with low responsiveness (red colour code) during the first 48 hours in the ICU

研究概览

简要总结

The Pilot Clinical Investigation planned is a prospective, unblinded randomized pilot trial comparing sedation management using a protocol based on responsiveness with standard sedation management. The hypothesis is that responsiveness will improve a range of patient-based and economic outcomes, including the duration of mechanical ventilation and duration of coma in the ICU. The purpose of the pilot study is to gather information for designing a full study that might show the validity of the outcome hypothesis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
None

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Patients mechanically ventilated via an endotracheal tube and receiving intravenous sedation with a hypnotic agent (midazolam or other benzodiazepine) or propofol by continuous infusion.

排除标准

  • •Primary intracerebral disorder (includes cardiac arrest with probable hypoxic brain injury; intrac-ranial haemorrhage; head injury causing reduced conscious level prior to intubation)
  • •Patient who is already awake at the time of enrolment defined as RASS ³ -1
  • •Age <16 years
  • •Patient not expected to survive the next 24 hours
  • •Patient receiving long term ventilation prior to ICU admission
  • •Patient with a long term tracheostomy prior to ICU admission
  • •Patient transferred sedated and mechanically ventilated from another ICU unless recruitment is possible within 24 hours of first ICU admission
  • •Patient receiving continuous neuromuscular blocking agent at the time of screening for enrolment
  • •Previously enrolled in the trial during a separate ICU admission during this hospital stay
  • •Status epilepticus
  • •Confirmed meningitis or encephalitis at the time of screening for enrolment
  • •Chronic neurological disease interfering with normal neuromuscular function, e.g. motor neurone disease, Guillain-Barre syndrome or inherited neuromyopathies

研究组 & 干预措施

Protocol

Experimental

Using sedation monitoring and protocol

干预措施: "Sedation Trial Monitor" is the name of the device used. (Device)

Control

No Intervention

Standard practice

结局指标

主要结局

Proportion of time spent with low responsiveness (red colour code) during the first 48 hours in the ICU

时间窗: 8 month period

The main purpose in the statistical analysis is not to test the statistical significance of the differences but to provide descriptive statistics for the full outcome study plan.

次要结局

  • Proportion of time spent with RASS score -4/-5 during the first 48 hours in the ICU.(8 months)

研究者

发起方
GE Healthcare
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验